Viking Thera (VKTX)
23.81 x 1 24.07 x 1
Post-market by (Cboe BZX)
25.68 +1.77 (+7.40%) 04/02/25 [NASDAQ]
23.81 x 1 24.07 x 1
Post-market 24.06 -1.62 (-6.31%) 19:53 ET
for Wed, Apr 2nd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 150,921 | 100,827 | 70,355 | 55,682 | 42,662 |
| Operating Income | -150,921 | -100,827 | -70,355 | -55,682 | -42,662 |
| Other Income | 40,958 | 14,932 | 1,488 | 692 | 3,167 |
| Pre-tax Income | -109,963 | -85,895 | -68,867 | -54,990 | -39,495 |
| Net Income Continuous | -109,963 | -85,895 | -68,867 | -54,990 | -39,495 |
| Net Income | $-109,963 | $-85,895 | $-68,867 | $-54,990 | $-39,495 |
| EPS Basic Total Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
| EPS Basic Continuous Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
| EPS Diluted Total Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
| EPS Diluted Continuous Ops | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -1.01 | -0.91 | -0.90 | -0.71 | -0.54 |
| EBITDA(a) | $-167,748 | $-108,649 | $-68,788 | $-51,462 | $-38,471 |